Morphoceuticals focuses on understanding and manipulating the bioelectrome to induce regeneration and treat disease.

Morphoceuticals

Morphoceuticals is a new biotech company creating the first map of the druggable bioelectrome. By using multi-omics, bioelectric profiling and AI, we aim to exploit the electrical network controlling tissue repair and organ regeneration that exists throughout our bodies.

Our CEO, James Jenson, caught up with Danny Sullivan at Longevity.Technology to talk about our progress toward building the first map of the druggable bioelectrome. Check it out here.

We are excited to welcome James Jenson, PhD as our CEO! With more than 35 years of experience in the biotech and pharmaceutical industries, as both an entrepreneur and executive leader, Jim joins our growing team as we build the first map of the druggable bioelectrome.
	
The ‘bioelectrome’ refers to electrical networks throughout the body, powered by ions rather than electrons as in metal wires. These electrical networks are the cognitive glue that binds multi-cellular collectives together to a common purpose, processing information that controls tissue repair and organ regeneration.

Read more here: https://bit.ly/3W4QGP4

David Kaplan, one of the founders of Morphoceuticals has been named a Fellow of the National Academy of Inventors.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Aug 26, 2024 12:56 AM	5c67525b
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Oct 31, 2024 9:55 AM	6d8b5013
crunchbase profile	general
li profile	general	Aug 26, 2024 12:56 AM	ca9ee8e7
translate crunchbase fundingrounds	general
peers	general	Aug 26, 2024 12:56 AM	2c9cbdfd
news basic	general	Aug 26, 2024 12:56 AM	c7c1067c
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

MORP

COM:MORPHOCEUTICALS

Morphoceuticals